e-learning
resources
Milan 2017
Monday, 11.09.2017
Implementation of respiratory physiotherapy interventions in clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rhythm and song: Breath management in Idiopathic Interstitial Pneumonias (IIP's). Pilot study.
A. Russell (London, United Kingdom)
Source:
International Congress 2017 – Implementation of respiratory physiotherapy interventions in clinical practice
Session:
Implementation of respiratory physiotherapy interventions in clinical practice
Session type:
Thematic Poster
Number:
2536
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Russell (London, United Kingdom). Rhythm and song: Breath management in Idiopathic Interstitial Pneumonias (IIP's). Pilot study.. 2536
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Respiratory sequelae of preterm birth across the life span
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021
Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Tracking crackles of Interstitial Lung Disease during sleep.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
ATS / ERS: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
Source: Guideline 2002
Year: 2002
Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB)
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations
Year: 2018
Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
LATE-BREAKING ABSTRACT: Bosentan in Pulmonary Hypertension associated with Fibrotic Idiopathic Interstitial Pneumonia:A Randomized, Double-Blind, Placebo-controlled Study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept